hexamethylene bisacetamide has been researched along with Leukemia, Megakaryoblastic, Acute in 1 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
Leukemia, Megakaryoblastic, Acute: An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, W | 1 |
| Pan, HQ | 1 |
| Ouyang, B | 1 |
| Greenberg, JM | 1 |
| Means, RT | 1 |
| Li, B | 1 |
| Cardie, J | 1 |
1 other study available for hexamethylene bisacetamide and Leukemia, Megakaryoblastic, Acute
| Article | Year |
|---|---|
Expression of receptor protein tyrosine kinase tif is regulated during leukemia cell differentiation.
Topics: Acetamides; Base Sequence; Cell Differentiation; Down-Regulation; Gene Expression Regulation, Enzymo | 1996 |